084 - Drug Discovery, Candidate Selection, Pre-Clinical Development, IND Submissions, Administration Route Selection, TPP and Toxicology with Marta New

On this episode, I was joined by Marta New, the CEO of Radyus Research. Dr. New discusses:

• (0:00) Intro
• (1:37) Pre-Clinical Planning
• (7:15) What's the purpose of an IND?
• (14:10) Administration Route Selection
• (19:00) Candidate Selection and Animal Models
• (30:10) Pre-IND Meeting
• (44:00) IND Submissions and Approval

Marta New PhD MBA is the CEO of Radyus Research. She is an experienced drug developer with a background in early-stage venture capital, considerable pharma R&D, and university technology transfer.